United Therapeutics Corporation (UTHR)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided does not include specific values for United Therapeutics Corporation's number of days of payables for any of the mentioned dates. Without this information, it is not possible to conduct an analysis or provide any insights regarding the company's payables turnover or payment practices. It is crucial to have the actual numerical data to assess the efficiency of the company's payables management and its impact on working capital.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
United Therapeutics Corporation
UTHR
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
45.00
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.51
Catalyst Pharmaceuticals Inc
CPRX
26.83